- OBD's PSE test to be used in NCI trial
- OBD develops multi-cancer diagnostic test for dogs
- Notice of Results
- OBD partners with Goodbody Clinic on PSE test
- OBD partners with The London Clinic for PSE & CiRT
- OBD and King's College London collaborate on RA
- Holding(s) in Company
- Results of GM
- OBD opens UK clinical testing facility
- Result of AGM
More ▼
Key statistics
On Friday, Oxford Biodynamics PLC (LMQ:FRA) closed at 0.0515, 14.44% above the 52 week low of 0.045 set on Sep 26, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.0515 |
---|---|
High | 0.0515 |
Low | 0.0515 |
Bid | 0.0505 |
Offer | 0.134 |
Previous close | 0.0775 |
Average volume | 20.00 |
---|---|
Shares outstanding | 311.86m |
Free float | 263.69m |
P/E (TTM) | -- |
Market cap | 27.10m GBP |
EPS (TTM) | -0.0729 GBP |
Data delayed at least 15 minutes, as of Jun 07 2024 07:02 BST.
More ▼